Alpha Square Group S, LLC Rani Therapeutics Holdings, Inc. Transaction History

Alpha Square Group S, LLC

  • $95.3 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$2.98 - $3.8 $76,124 - $97,071
-25,545 Reduced 43.34%
33,401 $103,000
Q4 2023

Feb 14, 2024
SELL
$1.85 - $3.67 $51,800 - $102,760
-28,000 Reduced 32.2%
58,946 $195,000
Q3 2023

Nov 14, 2023
SELL
$2.17 - $4.44 $31,740 - $64,943
-14,627 Reduced 14.4%
86,946 $188,000
Q1 2023

May 15, 2023
SELL
$5.07 - $6.89 $152 - $206
-30 Reduced 0.03%
101,573 $524,000
Q4 2021

May 13, 2022
BUY
$16.09 - $35.0 $1.63 Million - $3.56 Million
101,603 New
101,603 $1.66 Million

Others Institutions Holding RANI

# of Institutions
35
Shares Held
5.77M
Call Options Held
2.5K
Put Options Held
2.2K
View Full List

About Rani Therapeutics Holdings, Inc.

RANI Quotes by TradingView
  • Ticker RANI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,492,000
  • Market Cap $38.9M
  • Description
  • Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...
More about RANI
Track This Portfolio

Track Alpha Square Group S, LLC Portfolio

Follow Alpha Square Group S, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Square Group S, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Square Group S, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email